BioNTech Newsroom

BioNTech Is Maintained at Buy by Canaccord Genuity

Dow Jones00:29

BioNTech Price Target Maintained With a $171.00/Share by Canaccord Genuity

Dow Jones00:29

BioNTech Analyst Ratings

Benzinga00:19

Goldman Sachs Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $137

Futu NewsNov 14 21:31

Analysts Are Bullish on Top Healthcare Stocks: Voyager Therapeutics (VYGR), BioNTech SE (BNTX)

TipRanksNov 14 21:26

CCORF Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $171

Futu NewsNov 14 20:31

Strategic Acquisition and Oncology Focus Justify BioNTech's Buy Rating

TipRanksNov 14 20:30

Leerink Partners Maintains BioNTech(BNTX.US) With Buy Rating, Announces Target Price $121

Futu NewsNov 14 02:31

Deutsche Bank Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $150

Futu NewsNov 12 21:33

Deutsche Bank Reaffirms Their Buy Rating on BioNTech SE (BNTX)

TipRanksNov 12 20:57

Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $145

Futu NewsNov 11 21:37

Goldman Sachs Upgrades BioNTech(BNTX.US) to Buy Rating, Raises Target Price to $137

Futu NewsNov 8 13:33

BioNTech Is Maintained at Hold by TD Cowen

Dow JonesNov 7 01:50

A Quick Look at Today's Ratings for BioNTech(BNTX.US), With a Forecast Between $110 to $145

Futu NewsNov 6 21:08

Promising Developments in BioNTech's Oncology Pipeline Drive Buy Rating

TipRanksNov 6 16:21

BioNTech Price Target Cut to $122.00/Share From $132.00 by TD Cowen

Dow JonesNov 6 03:04

A Quick Look at Today's Ratings for BioNTech(BNTX.US), With a Forecast Between $122 to $171

Futu NewsNov 5 21:08

BioNTech SE (BNTX) Receives a Hold From Oppenheimer

TipRanksNov 5 20:59

Deutsche Bank Sticks to Their Buy Rating for BioNTech SE (BNTX)

TipRanksNov 5 19:42

BioNTech SE: Strong Financial Performance and Promising Future Justify Buy Rating

TipRanksNov 5 19:28